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The contribution of Mycobacterium bovis to the global burden of tuberculosis (TB) in man is likely to be
underestimated due to its dysgonic growth characteristics and because of the absence of pyruvate in
most used media is disadvantageous for its primary isolation. In Brazil Mycobacterium culture, identiﬁ-
cation and susceptibility tests are performed only in TB reference centers, usually for selected cases.
Moreover, solid, egg-based, glycerol-containing (without pyruvate supplementation) Löwenstein-Jensen
(L-J) or Ogawa media are routinely used, unfavouring M. bovis isolation. To determine the importance of
M. bovis as a public health threat in Brazil we investigated 3046 suspected TB patients inoculating their
clinical samples onto routine L-J and L-J pyruvate enriched media. A total of 1796 specimens were culture
positive for Mycobacterium spp. and 702 TB cases were conﬁrmed. Surprisingly we did not detect one
single case of M. bovis in the resulting collection of 1674 isolates recovered from M. bovis favourable
medium analyzed by conventional and molecular speciation methods. Also, bacillary DNA present on 454
sputum smears from 223 TB patients were OxyR genotyped and none was recognized as M. bovis. Our
data indicate that M. bovis importance on the burden of human TB in Brazil is marginal.
 2010 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Tuberculosis (TB) is primarily a disease of the lung, caused by very
closely related mycobacteria belonging to the Mycobacterium tuber-
culosis complex (MTC). The complex includes the following species:
M. tuberculosis, Mycobacterium africanum, Mycobacterium bovis, and
M. bovis-BCG, Mycobacterium microti, Mycobacterium caprae, Myco-
bacterium pinnipedii, and Mycobacterium canettii.1e3 By far, the most
importantagentofhuman tuberculosis isM. tuberculosis, accountable.
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r OA license.for more than 90% of cases.4 Whereas M. tuberculosis is mainly
a human pathogen, M. bovis has a broader host range, being mostly
observed in cattle but sometimes reported as responsible for disease
in other species. Noteworthy, M. bovis is naturally resistant to pyr-
azinamide, a ﬁrst-line anti-TB drug.5 Therefore, M. bovis detection,
beyond its importance in the identiﬁcation of outbreaks and epide-
miological links, has also implications for planning the most appro-
priate anti-TB therapeutic regimen and public healthy interventions.
In the case of human TB,M. bovis is reported worldwide as being
the second most frequent causative agent, estimated as being
responsible for approximately 5% of the global tuberculosis cases.6
InfectionwithM. bovis has accounted for a proportion ranging from
0.5 to 7.2% of all patients with a bacteriologically proven tubercu-
losis in industrialized countries.7 However, it is generally though
that in developing countries, M. bovis infection constitutes a more
severe threat to public health and might account for up to 10e15%
of the yearly registered new cases of human tuberculosis.6e8
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unpasteurized milk or, alternatively, inhalation of droplet nuclei.7,8
Although the anatomic site of human M. bovis disease is more
often extra-pulmonary, human disease caused by M. bovis and
M. tuberculosis are clinically, radiologically, and histopathologically
indistinguishable.9,10 Therefore, pathogen differentiation at species
level requires the observation of phenotypic characteristics that
include colonymorphology, growth rate, andbiochemical properties
after culturing on appropriate medium.10 In most developing coun-
tries, diagnosis of human TB is based on direct microscopic exami-
nation of specimens after acid-fast staining and chest radiography.
Some TB reference laboratories perform culture on the Mycobacte-
rium selective Löwenstein-Jensen (L-J) medium and biochemical
tests to differentiate isolates, eventually including some that
distinguish M. tuberculosis from M. bovis. However, even in these
laboratories the use of the egg-medium containing pyruvate and
semi-synthetic media inwhich the bovine bacillus would preferably
grow is greatly limited.11 Hence, the difﬁculty in obtaining primary
isolates ofM.bovisusing conventional L-Jmedium is amajor obstacle
to ascribe the contribution ofM. bovis to the burden of human TB in
developing countries. To investigate the role of M. bovis in the
etiology of human tuberculosis cases in Brazil, particularly in Rio de
Janeiro, we conducted a study that added to conventional myco-
bacterial culturing and identiﬁcation procedures, culturing on glyc-
erol-free pyruvate containing L-J medium and genetic analysis.
Additionally we performed direct genotyping of material present on
ZiehleNeelsen (ZeN) stained slides that hadbeenprepared aspartof
standard TB diagnostic workout.
2. Materials and methods
2.1. Study setting and design
Virtually all commercially available milk supply is pasteurized in
Brazil. Estimated Brazilian bovine population is 195millions and the
prevalence of tuberculin reactors animals range between 0.37% (in
the Southern-Eastern) and 3.62% (in the Northern States).12 Around
20% of Brazilian dairy cattle farms are thought to be affected by
bovine tuberculosis. In a survey conducted in Rio de Janeiro state
12.7% of tested animals were tuberculin reactors.13 However, the
magnitude of bovine tuberculosis may be yet more serious in Brazil.
Isolated animals and small herds, in areas comprising subsistence
farming and pastoral communities, are usually not tested for
M. bovis infection. Such areas are present even in the periphery of
Brazilian metropolitan regions and people living in these areas may
be exposed to unpasteurized milk and dairy products and meat of
infected animals.
World Health Organization estimated as 92,000 the number
of new human TB cases in Brazil for 2007 (an incidence rate of 48
per 100,000 individuals). The overall estimated prevalence of
M. tuberculosis infection among adults was 60 per 100,000 inhabi-
tants. Themortality rate fromtuberculosis in Brazilwas estimated to
be 4.4 per 100,000 persons (8400 deaths/year in 2007).14 Approxi-
mately 14% of adults with TB are thought to be HIV positive, and an
estimated 20% of people living with HIV/AIDS have pulmonary
tuberculosis.15 Rio de Janeiro is the second largest city in Brazil, with
5.8 million inhabitants. In 2005, Rio de Janeiro City had 8713 TB
cases and an incidence rate of 105.5 per 105 persons, almost twice as
high as the rest of the countryoverall.16 In total, 377deaths related to
TB were registered in 2003, with an incidence of 6.3 per 105
persons.15 Ofﬁcial ﬁgures estimate that 8% of adult TB patients in Rio
de Janeiro have HIV infection.16 The Clementino Fraga Filho
University Hospital/Institute of Thoracic Diseases of the Federal
University of Rio de Janeiro (FURJ), serves a population of 1 million
persons. Its Mycobacteriology Laboratory provides mycobacterialculture support to the University Hospital as well as to the City
Health Care centers and performs 5000 cultures annually, 20% of
which are positive for growth of mycobacteria. During a 20 months
period (fromApril 2005 toNovember 2006) 8833 clinical specimens
from suspected TB cases, routinely handled at our laboratory, were
enrolled in the study. Additionally, to extend our investigation to
regions where the risk forM. bovis infection is thought to be greater
than in Rio Metropolitan area, samples from other two Brazilian
regions and their related rural area (where pyruvate supplemented
media and even L-J routine culture were not available) were also
analyzed: 1) Campos, 300 km away from Rio de Janeiro, a mixed
urbanerural municipality (0.5 million inhabitants) displaying
unfavorable economic and human development indices that has its
economy historically linked to the cattle farming, subsistence
farming and sugar cane industry; 2) Four municipalities in the State
ofMinas Gerais having important cattle and dairy farming activities.
Each geographical area represents a different eco-epidemiological
setting. During a 12 months period (from December 2007 to
November 2008) a total of 454 smear-positive samples corre-
sponding to 223 pulmonary TB patients (some patients have more
than one slide available to be examined) from these two regions
were analyzed.
2.2. Handling of clinical specimens and culture conditions
As it is generally believed thatM.bovisgrowthor, at least, optimal
growth is constrained by using media without pyruvate supple-
mentation and/or containing glycerol, we performed, in parallel to
culturing on conventional L-J medium supplemented with glycerol,
inoculationof all clinical specimens on tubeswith L-J thatwas freeof
glycerol and supplemented with 5 mg/ml sodium pyruvate (Sig-
maeAldrich, St. Louis, Missouri, USA). We collected a total of 8833
specimens from 3046 suspected TB patients and replicate patient
samples were due either because of collection from different body
sites and/or on different days. The median number of samples
collected per patient was three. For culturing, clinical specimens
were homogenized, submitted to N-acetyl-cysteine digestion and
sodium hydroxide decontamination and centrifuged 2 times at
3000g for 15 min. Aseptically collected ﬂuids and tissues were
centrifuged without previous digestion or decontamination. The
sediment was resuspended and divided into three equal volumes.
Two 200 ml aliquots were plated onto L-J.16 The third aliquot were
plated onto L-J, without glycerol, pyruvate enriched agar slants (L-J
pyruvate). All inoculated slants were incubated at 37 C for eight
weeks and submitted to standardized observation protocol, after
48e72 h, and later on twice weekly. After 60 days, bacterial counts
were deﬁned by colony numbering from 1 to 19, or scored þ1
(20e100 colonies), þ2 (>100 individual colonies) or þ3 (conﬂuent
colonies).17 Growth on the L-J slants resembling mycobacterial
colonies (i.e., rough, tough and buff-colored), was subjected to ZeN
staining and Gram staining to conﬁrm the presence of acid-fast
bacilli and rule out contamination. As a control procedure, we also
inoculated fourM. bovis (M. bovis ATCC 19210,M. bovis AN5,M. bovis
[bovine clinical strain],M. bovis BCG 35736) and twoM. tuberculosis
strains (M. tuberculosis H37Ra ATCC 25177, M. tuberculosis [human
clinical strain]) onto triplicate agar slants of both L-J media types
(with glycerol or pyruvate) that were also incubated at 37 C for 60
days. Themean of the triplicatewas recorded as the colony count for
the entire culture.
2.3. Phenotypic and biochemical characterization of bacterial
isolates
For differentiation of Mycobacterium spp. of the MTC from
mycobacteria other than tuberculosis (MOTT), we observed
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growth and biochemical tests.17,18 Differentiation between some of
the MTC members was achieved by analyzing phenotypical and
biochemical features, including production of niacin, nitrate reduc-
tion, semi-quantitative catalase activity and catalase thermo stability
at 68 C, as previously described by Kent & Kubica.17
2.4. Genotyping
For genotyping ofMTCDNApresent in cultures a loop of bacterial
masswas taken fromcultures in L-J pyruvatemedium, suspended in
0.5 ml of 10 mM Tris-HCle1 mM EDTAe1% Triton X-100 and incu-
bated at 100 C for 10 min after vigorous mixing. Nucleic acids and
processed cultures were stored at 20 C until further use. Spoli-
gotypingwas performed using PCR and hybridization conditions on
a commercially available membrane (Isogen Bioscience BV, Maars-
sen, The Netherlands) as previously described19 and including
(M. tuberculosis andM. bovisDNA) controls in every batch of tests. As
a supplementary test for differentiation of M. tuberculosis from M.
bovis, we performed PCR-REA of a 726 bp fragment including the full
pncA gene (561 bp) as described by Barouni et al.20 The pncA gene
contains a polymorphic site at position 169 that permits the
distinction betweenM. bovis andM. tuberculosis. In brief, the 726 bp
fragment was generated using the primers 50 GTC GGT CAT GTT CGC
GAT CG30and 50 GCT TTGCGGCGAGCGCTCCA 30.20 Thermal cycling
conditionswere: initial denaturation at 95 C for 4min; followed by
35 cycles of denaturation at 94 C for 1 min, annealing at 68 C for
2min and extension at 72 C for 1min. An additional extension step
at 72 C for 10 min was included at the end of 35-th cycle. PCR
ampliﬁcations were digested with Eco065 I and resolved on a 5%
agarose to determine the presence of the allelic variant of M. Bovis.
In addition to the genotyping of the clinical samples described
above, we also performed genetic characterization of bacilli present
in 454 ZeN stained sputum smears corresponding to 223 pulmo-
nary TB cases. Patients were from two different Brazilian regions,
including 140 (303 positive ZeN slides) from Campos, Rio de
Janeiro State and 83 (151 positive ZeN slides) from four munici-
palities of the Minas Gerais State. The presence of acid-fast bacilli
(AFB) was quantiﬁed by microscopy and recorded as þ (less than 1
bacillus per 100 examined ﬁelds),þþ (1e10 bacilli per 50 examined
ﬁelds) and þþþ (more than 10 bacilli per 20 examined ﬁelds). The
slides had been stored at room temperature for no longer than
eight weeks before DNA extraction, the latter achieved by a proce-
dure adapted from van der Zend et al.21 Brieﬂy, residual oil present
on the glass slides was removed with xylol (Merck, Darmstadt,
Germany), rinsed with distilled water and the biological material
removed from the surface by scraping with a #14 lancet after
spotting 25 ml of sterile distilled water. This suspension was
transferred to a microcentrifuge tube containing 200 ml of a 15%
Chelex 100 (SigmaeAldrich, St. Louis, Missouri, USA) suspension
and after vigorous shaking, incubated at 95 C for 30 min. The
samples were then centrifuged for 10 min at 13,000g and the
supernatant removed and stored at20 C until further analysis. As
single point mutations of the pncA gene5 has been used to differ-
entiate between M. bovis and M. tuberculosis PCRs were performed
to amplify a 726 bp fragment including the full pncA gene. Almost
all pncA PCRs failed to amplify. Assuming that the mycobacterial
DNA present on the ZeN stained slides could have been signiﬁ-
cantly degraded, we realized that PCR ampliﬁcation of targets of
more than 150e200 bp may be difﬁcult. For this reason we used
primers previously described by Taylor et al. for amplifying
a smaller 150 bp oxyR gene fragment22 and determine nucleotide at
oxyR gene position 285 to differentiate M. bovis from M. tubercu-
losis.23 The sequence of these primers is 50 CGCGCTGTCA-
GAGCTGACTTT 30 (forward) and 50 TCTGCGGAATCAGTGTCACC 30(reverse). The cycling conditions were: initial denaturation at 94 C
for 1 min; followed by 45 cycles consisting of 1 min at 94 C, 1 min
at 60 C, 1 min at 72 C. An additional extension step at 72 C for
10 min was included at the end of 45-th cycle. After agarose gel
electrophoresis, the 150 bp ampliconwas puriﬁed and the presence
of the single nucleotide A/G polymorphism at position 285,
distinctive of M. bovis, was veriﬁed by sequencing. Sequencing
reactions were performed using the BigDye Terminator 3.1 Cycle
Sequencing kit and electrophoresis was performed under standard
conditions on an ABI 3730 automated sequencer (Applied Bio-
systems). The sequence data were analyzed with SeqScape soft-
ware version 2.5 (Applied Biosystems) and compared with the
published sequence of oxyR (GenBank accession number U18263).
2.5. Data analysis
The two-proportion Z-test was used to compare mycobacterial
growth on the different media used in the study. Fisher’s exact test
wasused to compare the numberof pulmonaryand extra-pulmonary
isolates that grew on L-J mediumwith those that grew exclusively L-J
pyruvate medium. A signiﬁcance level of 5% was considered. Spoli-
gotype patterns were recorded both in a 43-digit binary format rep-
resenting the 43 spacers and as an octal code24 and initially veriﬁed
for the presence of spacers that differentiate M. tuberculosis from
M. bovis. In addition, M. tuberculosis patterns were introduced
into a Microsoft Ofﬁce Excel datasheet for cluster recognition and
classiﬁcation and then compared with the SpolDB4 database of the
Pasteur Institute of Guadeloupe (http://www.pasteur-guadeloupe.fr:
8081/SITVITDemo) for type classiﬁcation. All isolates that yielded
spoligotypes that were recognized as not previously described
patterns were submitted to at least one additional spoligotyping
assay and only considered when conﬁrming the ﬁrst pattern.
3. Results
3.1. Mycobacterial growth on routine L-J and L-J pyruvate medium
3.1.1. Control strains
As someone could argue that inherent problems within the
pyruvate supplementedmediummight account for the failure ofM.
bovis “truly” positive specimens to yield identiﬁable mycobacterial
growth we carried out a growth control assay. Standard collection
and clinical MTC strains were inoculated on L-J and L-J pyruvate.
Their growth rates on each and bothmedia are shown in Table 1. All
tested M. bovis reference strains grew adequately on pyruvate
supplemented media.
3.1.2. Clinical specimens strains
From the 26,499 slants that were inoculated with 8833 clinical
specimens from 3046 suspected TB cases 17,666 cultures on routine
L-J and 8833 cultures on L-J supplemented with pyruvate, were
observed during a 60 days period.Overall,1796 clinical specimens out
of 8833 (20.3%) produced 3365 positivemycobacterial cultures in one
or both media. Most of specimens (1593, 88.6%) were pulmonary
while 203 (11.4%) % were obtained from an extra-pulmonary site. The
majority of the isolates (3001, 89.2%) were obtained from the 1593
pulmonaryspecimens.Among thepulmonary isolates, 66%originated
from sputum, 27.1% from induced sputum, 6.9% from bronchoalveolar
lavage ﬂuid and 1% from other related specimens. An extra-pulmo-
nary site was the origin of 364 (10.8%) isolates recovered from 203
samples. Taking into account the sum of extra-pulmonary isolates,
28% originated from lymph nodes, 27% from blood or bone marrow,
12% from pleura and the remaining 33% from various other tissues.
Table 2 shows the distribution of 3365 isolates recovered from
1796 culture positive specimens, obtained from702 TB patients and
Table 1
Mycobacterium bovis and Mycobacterium tuberculosis collection and clinical strains
culture yield in standard Löwenstein-Jensen (L-J) and glycerol-free Löwenstein-
Jensen medium supplemented with sodium pyruvate (L-J pyruvate).
Mycobacterial strain Culture Yield*
L-J medium L-J pyruvate medium
Mycobacterium bovis ATCC 19210 5 þ
Mycobacterium bovis BCG 35736 þ þ
Mycobacterium tuberculosis
H37Ra ATCC 25177
þ þ
Mycobacterium bovis AN5  þ
Mycobacterium tuberculosis
human clinical strain
þ þ
Mycobacterium bovis bovine
clinical strain
 þ
* Mycobacterial culture yield expressed as null if no growthwas observed after 60
days () deﬁned by colony numbering from 1 to 19, or scored þ (20e100 colonies).
The mean of the triplicate was recorded as the colony count for the entire culture of
each strain tested.
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to their medium or media of growth. Most of the pulmonary and
extra-pulmonary strains grew on both L-J and L-J pyruvate
medium: 1408 out of 1593 culture positive pulmonary samples
(88.4%) and 161 out of 203 culture positive extra-pulmonary
samples (79.3%). A similar proportion of pulmonary and extra-
pulmonary strains were recovered from L-J pyruvatemedium: 1478
from 1593 culture positive samples (92.7%) and 196 out of 203
culture positive samples (96.5%) (p-value¼ 0.062). Among the 1593
pulmonary specimens a comparable proportion of strains was
recovered from L-J (1523/1593, 95.6%) and L-J pyruvate medium
(1478/1593, 92.7%). However, for the 203 extra-pulmonary speci-
mens the proportion of strains recovered from L-J pyruvate
(196/203, 96.5%), was greater than that recovered from L-J medium
(168/203, 82.8%) (p-value< 0.001). Some strains grew only on L-J or
only on L-J pyruvate medium. Interestingly, when comparing the
number of extra-pulmonary strains that grew exclusively on L-J
(7/203, 3.4%) or exclusively on L-J pyruvatemedium (35/203,17.3%),
extra-pulmonary strains appeared to express preferential growth
on L-J pyruvate. Five-fold more extra-pulmonary mycobacterial
isolation was observed exclusively on L-J pyruvate than exclusively
on L-J medium (p-value < 0.001). Also, when comparing the
number of pulmonary and extra-pulmonary strains that grew on L-J
with those that grew exclusively L-J pyruvate (shown in Table 2),
we observed a statistically signiﬁcant higher number of extra-
pulmonary strains recovery exclusively from L-J pyruvate medium
(70/1523 versus 35/203, respectively for pulmonary and extra-
pulmonary strains [p < 0.001]). No such difference was observed in
the case of inoculates derived from pulmonary specimens.
3.2. Phenotypic and biochemical characterization of isolates
The great majority (1678, 93.5%) of the 1796 culture positive
specimens resulted on the isolation of 3182 strains that were typedTable 2
Distribution of the 3365 isolates from 1796 culture-positive samples (corresponding to 7
glycerol-free Löwenstein-Jensen medium supplemented with pyruvate (L-J pyruvate).
Source N Culture þ specimens Isolates growth pattern in
L-J L-
Pulmonary 1593 (88.7%) 1523 (95.6%) 14
Extra-pulmonary 203 (11.3%) 168 (82.8%) 1
Totals 1796 1691 (94.2%) 16
The number of isolates is given (followed in parentheses by the percentage) in relation
culture positive specimens.
All 1796 culture positive specimens were obtained from 702 TB cases and 78 cases of Mas MTC spp. while 118 (6.5%) resulted on the isolation of 183 MOTT
strains. Most of MOTT isolates were recognized among pulmonary
samples (108/118, 91.5%) and only 10 among extra-pulmonary ones
(8.5%). Overall, considering the 3365 strains that grew on L-J
pyruvate and/or L-J standard media, 183 (5.4%) were identiﬁed as
MOTT and 3182 (94.6%) as MTC spp. It is noteworthy that inocula-
tion on L-J pyruvate medium did not particularly favored growth or
recovery of MOTT strains neither from pulmonary nor extra-
pulmonary sites (data not shown). None of the 1674 mycobacterial
isolates obtained from L-J pyruvate was identiﬁed as beingM. bovis.
All MTC isolates (from one or both media) presented values of
phenotypic features and biochemical tests indicative of M. tuber-
culosis. Data concerning details about possible intermediate strains
or grouping of isolates characteristics will be discussed elsewhere
(manuscript in prep.). As it is commonly accepted that M. bovis
growth or, at least, optimal growth is constrained by using media
without pyruvate supplementation and/or containing glycerol, we
performed the rest of the analytical procedures aimed at the
identiﬁcation of M. bovis as an etiologic agent of human TB only on
isolates recovered from the L-J pyruvate, glycerol free medium.3.3. Genotyping of bacterial isolates recovered from L-J pyruvate
medium of patients from Rio de Janeiro
Among the 1674 isolates that were observed on L-J pyruvate 239
(14.2%) could not be submitted to genetic analysis, due medium
degradation, contamination or loss during transfer and storage
(153/239, 64%) or were excluded because they were identiﬁed as
MOTT (86/239, 36%). The rest (n ¼ 1435) was submitted to geno-
typing using the assays for pncA and spoligotyping. Workable PCR
ampliﬁcation and RFLP analysis of the pncA genepolymorphic site at
position 169was obtained for 1161 (81%) of the 1435 isolates and all
showed the M. tuberculosis pattern. Good quality spoligo patterns
were generated for 989 (69%) of the isolates and all presented
genotypes characteristic forM. tuberculosis (using as reference data
available on SpolDB4)24 and SITVIT databases (http://www.pasteur-
guadeloupe.fr:8081/SITVITDemo/). Data on genotyping outcome
and source of the 1674 mycobacterial isolates recovered from L-J
pyruvate medium are summarized in Table 3. The spoligotype
results are provided asM. tuberculosis families and their frequencies
among the analyzed isolates in Table 4. Considering SpolDB4 as
a source for recognition of spoligotypes reported elsewhere, we
observed that 858 of these isolates (86.8%) presented spoligotypes
that were also present in the database while the remaining 131
(13.2%) segregated into 22 newly identiﬁed spoligotype patterns,
not reported by SpolDB4. Among the formerly described genotypes,
those belonging to the LAM family were most frequently observed
(423/989, 42.7%), being mostly LAM9 (166/423, 39.2%) and about
70% (114/166) of these identiﬁed as LAM9-type 42. Other frequently
observed families were H3 (117/989, 11.8%) with type 50 present in
78.6% of such isolates, T1 (117/989, 11.8%) with the type 53 being
most frequent (45.3%), H1 (62/989, 6.2%) presenting type 47 in 84%02 TB cases) according to their growth in the Löwenstein-Jensen (L-J) and/or in the
L-J and L-J pyruvate medium
J Pyruvate Both Media Only L-J Only L-J Pyruvate
78 (92.7%) 1408 (88.4%) 115 (7.2%) 70 (4.3%)
96 (96.5%) 161 (79.3%) 7 (3.4%) 35 (17.2%)
74 (93.2%) 1569 (87.3%) 122 (6.8%) 105 (5.8%)
to the number of pulmonary (row 1), extra-pulmonary (row 2) and total (row 3) of
OTT infection enrolled at Rio de Janeiro.
Table 3
Summary data on genotyping outcome and source of the 1674mycobacterial isolates
from Löwenstein-Jensen pyruvate medium.
N of Isolates *, y Comment Pulmonary Extra-pulmonary
1674 (100%) Total recovered from
L-J pyruvate
1478 (88.3%){ 196 (11.7%){
239 (14.2%){ Excluded**, not submitted
to genotyping
213 (89.1%) 26 (10.9%)
1435 (85.8%){ Submitted to genotypingz 1265 (88.1%) 170 (11.9%)
989 (69.1%){ Successfully spoligotyped 892 (90.2%) 97 (9.8%)
1161 (81%){ Successfully pncA genotyped 1042 (89.8%) 119 (10.2%)
* All 1674 Löwenstein-Jensen pyruvate isolates and 1691 standard Löwenstein-
Jensen isolates (not shown in this table), from a total of 3365 isolates which were
recovered from 1796 culture positive samples, corresponding to 702 TB patients and
78 cases of MOTT infection.
y All patients and samples were enrolled at Rio de Janeiro.
{ The number of isolates is given (followed in parentheses by the percentage) in
relation to the total number of L-J isolates (column 1, lines 2 and 3), to the total of
1435 isolates submitted to spoligotyping (column 1, lines 4 and 5) and to the
number of isolates stated in the column 1 (columns 3 and 4).
** 153 isolates were excluded due medium degradation, contamination or loss
during transport/storage and 86 because they were identiﬁed as MOTT.
z Spoligotyping and pncA genotyping were performed only on MTC isolates
recovered from the L-J pyruvate medium.
A. Rocha et al. / Tuberculosis 91 (2011) 14e2118of this grouping, LAM2 (58/989, 5.8%), LAM6 (56/989, 5.6%) mainly
represented by type 64 (87%) and LAM3 (44/989, 4.4%).
3.4. Genotyping of MTC present on ZiehleNeelsen stained smears
Mycobacterial DNA was obtained directly from AFB positive
sputum smears produced during routine TB diagnosis workup in
two different Brazilian regions (Campos, Rio de Janeiro State and
fourmunicipalities in the State ofMinasGerais)where cultureswere
not available. At ﬁrst, we attempted to differentiate betweenTable 4
Mycobacterium tuberculosis spoligotype families and their frequencies among the
989 analyzed isolates.
Spoligotyping family Number Percentage
EAI5 4 0.4
EAI6_BGD1 1 0.1
H1 62 6.3
H2 2 0.2
H3 117 11.8
H4 1 0.1
LAM1 40 4.0
LAM1-LAM4 3 0.3
LAM2 58 5.9
LAM2-LAM4 3 0.3
LAM3 44 4.4
LAM3 and S/convergent 9 0.9
LAM4 17 1.7
LAM5 27 2.7
LAM6 56 5.7
LAM9 166 16.8
MAMU2 1 0.1
S 9 0.9
T1 117 11.8
T2 12 1.2
T2-T3 12 1.2
T3 22 2.2
T4 1 0.1
T4-CEU1 5 0.5
T5 1 0.1
T5_MAD2 6 0.6
U 34 3.4
U (likely H) 1 0.1
X1 3 0.3
X2 19 1.9
X3 5 0.5
New patterns 131 13.2
Total 989 100.0M. bovis andM. tuberculosis as the mycobacterial species present on
the sputum smears pointing out the distinctive pncA gene single
nucleotide point mutation at position 169. However, in our hands
almost all pncA PCRs failed to amplify directly from smears. The few
pncA gene fragments (726 bp) that were successful ampliﬁed pre-
sented theM. tuberculosis pattern. Next, a smaller,150 bp, oxyR gene
fragment was amplifyed22 and nucleotide at position 285 deter-
mined by sequence analysis to identify the species.23 The oxyR
genotyping fragment was successfully ampliﬁed and sequenced in
122 of the 303 (40%) AFB positive smears, corresponding to 49 of the
140 (35%) Campos TBpatients and in 91 of the 151 (60%)AFBpositive
smears, corresponding to 58 of the 83 (69.8%) Minas Gerais TB
patients. In all 213 successfully oxyR genotyped positive sputum
smears, corresponding to 107 TB cases, the G nucleotide at position
285, characteristic of M. tuberculosis, was determined. Data on
genotyping outcome of the 454 ZeN stained smears obtained from
223 pulmonary TB patients are summarized in Table 5.
4. Discussion
Human disease caused by M. bovis and other species of the MTC
are similar, although the anatomic site of M. bovis disease is more
often extra-pulmonary. Thus, collecting clinical samples from extra-
pulmonary sites is an excellent strategy to identify cases of M. bovis
human disease. Cases of human TB with M. bovis are mainly associ-
ated with the consumption of unpasteurized dairy products or close
contactwith infectedanimals.7Nevertheless, epidemiologic evidence
supports the likelihood of human-to-human, airborne M. bovis con-
tagion25e28 and this issue has been considered as possibly relevant to
the epidemiology and dynamics of human tuberculosis, at least in
developing countries. Thus, studies aimed at the identiﬁcation of the
bovine bacillus in both, extra-pulmonary and respiratory samples,
would be helpful to better understand the role of M. bovis as an
etiologic agent of human TB. Results from a study comparing spoligo
patterns indicate that the population of M. bovis strains causing
human TB disease in Southern California is closely related to the M.
bovis strain population found in Mexican cattle suggesting that
humanM. bovis disease in San Diego likely originated from Mexican
cattle.28 A recent report describes an outbreak of sputum-positiveM.
bovis disease transmitted by person-to-person contact in United
Kingdom.27 Moreover, Etchechoury et al. studying samples from 448
TBpatients fromdifferent regions ofArgentina, identiﬁed400 isolates
with representative PRA (PCR-restriction fragment analysis patterns
of mycobacterium. Further analysis of samples with MTC proﬁles
identiﬁed nineM. bovis strains indicating that that 2% of pulmonary
tuberculosis was due to M. bovis.29 In developing countries M. bovis
infection is highly prevalent in farmed animals13 and its contribution
to the burden of human TB in these regions could bemore important
than it is generally thought. Also, it is well known that co-infection
with HIV favors M. bovis transmission leading rapidly to disease
development30,31 and the high rates of HIV infection seen in most of
the developing countries may increase the risk for the development
human TB due to M. bovis. M. bovis grows poorly, or not at all, on
standard glycerol-containing media but its growth is stimulated by
sodium pyruvate. The pyruvate requirement of mostM. bovis strains
is the basis of one of the major phenotypic differences between M.
bovis andM. tuberculosis and seems to be due to a point mutation in
the pyruvate kinase gene, resulting in a defective glycerol metabo-
lism.32 Löwenstein-Jensen with pyruvate (but without glycerol),
Stonebrink, modiﬁed Middlebrook 7H11 and tuberculosis bovine
blood agar are considered the media of choice for the primary isola-
tion of M. bovis.33 We hypothesized that the extensive use of unfav-
ourablemedia forM. bovis coupledwith limited use of discriminatory
biochemical and genotypic tests should be considered as a potential
cause of under-reporting of M. bovis-related human disease. In
Table 5
Summary data and genotyping outcome of the 223 pulmonary TB patients and 454 diagnostic sputum smears used to perform direct OxyR genotyping from ZiehleNeelsen
stained slides.
Geographical location Totals
Campos,* 300 km away from Rio Four municipalities in the State of Minas Geraisy
TB cases enrolled{ 140 (62.8%) 83 (37.2%) 223 (100%)
TB cases in which oxyR genotyping was obtained{ 49 (35%) 58 (70%) 107 (48%)
Smear-positive Samples studied{ 303 (67%) 151 (33%) 454 (100%)
Smear-positive samples successfully oxyR genotyped{ 122 (40.3%) 91 (60.3%) 213 (47%)
M. Tuberculosis oxyR genotype{ 122 (100%) 91 (100%) 213 (100%)
M. bovis oxy R genotype{ 0 (0%) 0 (0%) 0 (0%)
* Mixed urbanerural municipality, 0.5 million inhabitants.
y Teóﬁlo Otoni (0.1 million inhabitants), Uberaba (0.3 million inhabitants), Montes Claros (0.4 million inhabitants), Juiz de Fora (0.5 million inhabitants).
{ The number of patients and sputum smears are given (followed in parentheses by the percentage) in relation to the totals presented in column 4 (lines 1e4) and to the
number of smears successfully oxyR genotyped (lines 4 and 5).
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bacillus among MTC isolates that had grown on inappropriate, non-
selective media may be contributing to the under-reporting of M.
bovishumandisease aswell. To verify this hypothesiswe investigated
3046 suspected TB patients plating their clinical specimens onto the
routine L-J slants and onto one supplementary L-J pyruvate enriched,
glycerol free, tube. Seven hundred two TB cases were conﬁrmed.
Mirroring the distribution of TB cases by site of disease in Brazil, 88%
of the isolates originated from the respiratory tract. Most of pulmo-
naryandextra-pulmonary isolateshadgrownwell onL-J, L-J pyruvate
or bothmedia. However, some strains expressed preferential growth
on L-J pyruvate medium, as reﬂected by ﬁve times more frequent
mycobacterial isolation when comparing the number of extra-
pulmonary strains that grew exclusively on L-J pyruvate medium
(35/203,17.3%) and exclusively on L-J (7/203, 3.4%) (p-value< 0.001).
This trend of some extra-pulmonary strains to preferentially grow on
L-J pyruvate medium could be due to: i) the higher proportion of
extra-pulmonary isolates that, as most M. bovis strains, could also
intrinsically present lesions in carbohydrate catabolism, namely
glycerol kinase and/or pyruvate kinase null or defective activity;
ii) pyruvate supplementationmight favor bacterial recovery from the
usually paucibacillary extra-pulmonary specimens enhancing
growth performance of small inoculi even ofMycobacterium spp. not
possessing intrinsic defects in carbohydrate metabolism.
Isolates of the MTC may be classiﬁed according to their
phenotypic characteristics or biochemical properties as strains that
completely fulﬁll the criteria forM. tuberculosis orM. bovis. For such
strains, no further characterization is usually performed. Never-
theless, some strains do not match all the required diagnostic
criteria and produce atypical phenotypic and biochemical identi-
ﬁcation test results. Sometimes the differentiation between these
two close-related MTC species (>99.95% of genome sequence
identity) by using classical methods may pose a challenge to the
microbiologist and could generate misleading results.34,35 Spoli-
gotyping is considered as a reliable conﬁrmatory genetic means for
the differentiation between M. bovis and M. tuberculosis and it is
particularly useful for strains with atypical biochemical identiﬁca-
tion test results.35 For this reason, after the initial phenotypic and
biochemical characterization, 1435 isolates recovered from the L-J
glycerol free, pyruvate supplemented medium were submitted to
spoligotyping. Patterns, adequate for analysis, were generated for
989 (69%) of these isolates. All of themwere conﬁrmed as MTC but
none was marked by the distinct loss of spacers 3, 9, 16 and 39e43,
individually or grouped, characteristic of M. bovis.24 Actually, all
successfully spoligotyped isolates were identiﬁed asM. tuberculosis.
As samples were not selected for any particular purpose the 989
successfully spoligotyped strains and their spoligopatterns should
be representative of the whole sample collection. However, it is
possible that some of the strains not yielding spoligotyping were in
fact M. bovis.Using the spoligotyping technique, differentiation of MTC
strains up to a subspecies level is also possible.24 Therefore, to
investigate the genetic diversity of M. tuberculosis strains circu-
lating in Rio de Janeiro, we compared the obtained spoligopatterns
with an updated international SpolDB4 database. Accordingly, the
isolates were segregated in 33 strain families, the LAM (Latin-
American and Mediterranean) spoligotype signature, characterized
by the simultaneous absence of at least spacers 21e24 and 33e36,
being the most frequently observed (423/989, 42.7%). Within this
family, LAM9 was the most frequently identiﬁed family pattern
(166/423, 39.2%). Other frequently observed families were H3, T1,
and H1. The Beijing pattern was not identiﬁed among the strain
families that could be grouped by SpolDB4. Overall, the proportion
of strains distribution M. tuberculosis major clades and sub-clades
observed here are in agreement with previous studies conducted
in Rio de Janeiro and Brazil.24,36,37 It is noteworthy that 13.2%
(131/989) of the isolates segregated into 22 newly identiﬁed spo-
ligotype patterns, not reported by SpolDB4.
Extending the search for humanM. bovis TB cases to eco-epide-
miological settings where the risk ofM. bovis infection is thought to
be greater than in Rio Metropolitan area, we also investigated
samples from other two Brazilian regions and their rural areas
harboring important dairy cattle activities and presenting high
index of cattleM. bovis infection. As the L-J pyruvate supplemented
media and even L-J solid media cultures are not available as a stan-
dard procedure during the TB diagnostic work in these municipal-
ities of Rio de Janeiro and Minas Gerais States, we performed direct
OxyR genotyping from 454 AFB positive ZiehleNeelsen stained
slides (303 from Campos and 151 fromMinas Gerais, corresponding
to 223 pulmonary TB patients) to identify any possibly present M.
bovis strain. The oxyR 150 bp gene fragment was successfully
ampliﬁed and sequenced from AFB-positive smears of 47.9% of the
223 studied pulmonary TB patients and in none, we observed the
presence of the A nucleotide at position 285, typical forM. bovis.
It is somewhat surprising that not a single case ofM.bovis-related
TB was evidenced among the 1678 MTC culture positive samples
from 702 TB patients, particularly considering that: i) a M. bovis
favourable medium was systematically used in the study ii) the
strains were isolated from3046 suspected TB cases (702 conﬁrmed)
and a large number (n ¼ 8833) of clinical specimens representative
of a broad spectrum of tissues and sites, including lymph nodes,
bone marrow, blood, bone and bowel biopsies; ii) the University
Hospital being a regional and national reference for TB, AIDS,
immuno-inﬂammatory diseases andhematologicalmalignancies an
important proportion of examined specimens were originated from
immunosupressed patients and iii) the University Hospital Gastro-
enterology Clinic being a regional reference for cases of infectious,
granulomatous and inﬂammatory bowel diseases several of such
cases are routinely under diagnostic investigation that not rarely
includes mycobacterial cultures. Also, as many of developing or
A. Rocha et al. / Tuberculosis 91 (2011) 14e2120transition countries and regions, Brazil, and particularly Rio de
JaneiroMetropolitan area and State, present high prevalence of both
bovine and humanTB and seems to present predisposing conditions
for the development of human M. bovis infection and disease.
Although almost all commercially available milk is pasteurized in
Brazil it was recently reported that 11 of 128 (8.5%) bovine milk
samples from retail markets in the State of São Paulo were
contaminated by M. bovis.38 In addition, small cow herds may be
found scattered all over the country, even in peripheral regions of
great cities like Rio. Small herd surveillance for infectious diseases
presents problems in developed39 and developing countries and is
certainly much more difﬁcult to be accomplished in countries like
Brazil. Actually, in Brazil, for such dispersed cow or cows this
surveillance may be completely non-existent. Moreover, a clearly
deﬁned slaughtering policy is not adopted inmost Brazilian regions
so people living in these areas are probably exposed to unpasteur-
ized milk, unpasteurized dairy products and meat from infected
animals. Even so, only few M. bovis-related TB cases have been
reported in Brazil11 and this picture remains unchanged evenwhen
lymph nodal and intestinal TB, TB associated with HIV and other
immunosuppressive conditions and TB cases from Brazilian rural
areas displaying poor economic indexes are taken in account. In
a retrospective survey, Kantor et al. reported that the proportion of
M. bovis-related human TB cases in 10 South America countries
ranged from 0% to 2.5%.11 Except for two cases from Ecuador, three
from Brazil and one from Venezuela, all reported M. bovis TB cases
were diagnosed in Argentina. Apparently in the other six investi-
gated countries (Chile, Colombia, Costa Rica, Dominican Republic,
Peru and Uruguay)M. bovis has never been isolated from humans.11
As vaccination with M. bovis BCG was introduced in Brazil in
1940 and has been systematically administered to virtually all
infants since 1976, some particular degree of speciﬁc protection
against the bovine tubercle bacillus provided by this thorough
vaccination might be one possible explanation for the paucity ofM.
bovis TB cases reported in our country. Nevertheless, most expert
comments on the burden of M. bovis in human TB emphasize that
the problem is most probably underestimated due to the limited
use of M. bovis favourable media and the inherent complexities of
phenotypical and biochemical speciation within the MTC.11 For this
reason, our study design was optimized for culturing and identiﬁ-
cation of MTC species, using conventional and molecular tools, and
the fact that we did not detect one single case of M. bovis in such
a large sample collection indicates that M. bovis importance on the
burden of human TB in Brazil is marginal.Acknowledgements
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